These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 18815192)

  • 21. Antibody binding capacity for evaluation of MDR-related proteins in acute promyelocytic leukemia: Onset versus relapse expression.
    Damiani D; Michieli M; Michelutti A; Candoni A; Stocchi R; Masolini P; Geromin A; Michelutti T; Raspadori D; Ippoliti M; Lauria F; Fanin R
    Cytometry B Clin Cytom; 2004 May; 59(1):40-5. PubMed ID: 15108169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autonomous proliferation of leukemic cells in vitro as a determinant of prognosis in adult acute myeloid leukemia.
    Löwenberg B; van Putten WL; Touw IP; Delwel R; Santini V
    N Engl J Med; 1993 Mar; 328(9):614-9. PubMed ID: 8429853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypomethylation of PRAME is responsible for its aberrant overexpression in human malignancies.
    Schenk T; Stengel S; Goellner S; Steinbach D; Saluz HP
    Genes Chromosomes Cancer; 2007 Sep; 46(9):796-804. PubMed ID: 17534929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Expression of PRAME gene in multiple myeloma].
    Abramenko IV; Belous NI; Kriachok IA; Chumak AA; Aksenova EV; Lisovskaia EV; Misiurin AV
    Ter Arkh; 2004; 76(7):77-81. PubMed ID: 15379133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Expression of PRAME gene in adult acute leukemia and its significance in prognosis].
    Zhou PY; Li WJ; Wei CX; Zhou Z
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1177-81. PubMed ID: 18088461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Therapy of acute promyelocytic leukemia in Czechia: results and analysis of prognostic factors].
    Schwarz J; Korístek Z; Starý J; Zák P; Kozák T; Marková J; Michalová K; Dvoráková D; Mayer J; Cetkovský P
    Vnitr Lek; 2008; 54(7-8):757-70. PubMed ID: 18780575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Childhood acute myelogenous leukaemia: association between PRAME, apoptosis- and MDR-related gene expression.
    Goellner S; Steinbach D; Schenk T; Gruhn B; Zintl F; Ramsay E; Saluz HP
    Eur J Cancer; 2006 Nov; 42(16):2807-14. PubMed ID: 16978861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The significance of minimal residual disease kinetics in adults with newly diagnosed PML-RARalpha-positive acute promyelocytic leukemia: results of a prospective trial.
    Lee S; Kim YJ; Eom KS; Min CK; Kim HJ; Cho SG; Lee JW; Min WS; Kim CC
    Haematologica; 2006 May; 91(5):671-4. PubMed ID: 16627255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Wilms tumour gene 1 overexpression in bone marrow as a marker for minimal residual disease in acute myeloid leukaemia.
    Hämäläinen MM; Kairisto V; Juvonen V; Johansson J; Aurén J; Kohonen K; Remes K; Salmi TT; Helenius H; Pelliniemi TT
    Eur J Haematol; 2008 Mar; 80(3):201-7. PubMed ID: 18081724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Real-time quantitative polymerase chain reaction detection of minimal residual disease by standardized WT1 assay to enhance risk stratification in acute myeloid leukemia: a European LeukemiaNet study.
    Cilloni D; Renneville A; Hermitte F; Hills RK; Daly S; Jovanovic JV; Gottardi E; Fava M; Schnittger S; Weiss T; Izzo B; Nomdedeu J; van der Heijden A; van der Reijden BA; Jansen JH; van der Velden VH; Ommen H; Preudhomme C; Saglio G; Grimwade D
    J Clin Oncol; 2009 Nov; 27(31):5195-201. PubMed ID: 19752335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of PRAME expression causes cell cycle arrest and apoptosis in leukemic cells.
    Tanaka N; Wang YH; Shiseki M; Takanashi M; Motoji T
    Leuk Res; 2011 Sep; 35(9):1219-25. PubMed ID: 21550659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection and treatment of molecular relapse in acute myeloid leukemia with RUNX1 (AML1), CBFB, or MLL gene translocations: frequent quantitative monitoring of molecular markers in different compartments and correlation with WT1 gene expression.
    Doubek M; Palasek I; Pospisil Z; Borsky M; Klabusay M; Brychtova Y; Jurcek T; Jeziskova I; Krejci M; Dvorakova D; Mayer J
    Exp Hematol; 2009 Jun; 37(6):659-72. PubMed ID: 19463768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of CD2 in acute promyelocytic leukemia correlates with short form of PML-RARalpha transcripts and poorer prognosis.
    Lin P; Hao S; Medeiros LJ; Estey EH; Pierce SA; Wang X; Glassman AB; Bueso-Ramos C; Huh YO
    Am J Clin Pathol; 2004 Mar; 121(3):402-7. PubMed ID: 15023045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical implications of PRAME gene expression in childhood acute myeloid leukemia.
    Steinbach D; Hermann J; Viehmann S; Zintl F; Gruhn B
    Cancer Genet Cytogenet; 2002 Mar; 133(2):118-23. PubMed ID: 11943337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myeloid antigen expression provides favorable outcome in patients with adult acute lymphoblastic leukemia: a single-center study.
    Yenerel MN; Atamer T; Yavuz AS; Kucukkaya R; Besisik S; Aktan M; Keskin H; Nalcaci M; Sargin D; Pekcelen Y; Dincol G
    Ann Hematol; 2002 Sep; 81(9):498-503. PubMed ID: 12373349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PRAME is a membrane and cytoplasmic protein aberrantly expressed in chronic lymphocytic leukemia and mantle cell lymphoma.
    Proto-Siqueira R; Figueiredo-Pontes LL; Panepucci RA; Garcia AB; Rizzatti EG; Nascimento FM; Ishikawa HC; Larson RE; Falcão RP; Simpson AJ; Gout I; Filonenko V; Rego EM; Zago MA
    Leuk Res; 2006 Nov; 30(11):1333-9. PubMed ID: 16620968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic regulation of PRAME gene in chronic myeloid leukemia.
    Roman-Gomez J; Jimenez-Velasco A; Agirre X; Castillejo JA; Navarro G; Jose-Eneriz ES; Garate L; Cordeu L; Cervantes F; Prosper F; Heiniger A; Torres A
    Leuk Res; 2007 Nov; 31(11):1521-8. PubMed ID: 17382387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The extent of minimal residual disease reduction after the first 4-week imatinib therapy determines outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Lee S; Kim YJ; Chung NG; Lim J; Lee DG; Kim HJ; Min CK; Lee JW; Min WS; Kim CC
    Cancer; 2009 Feb; 115(3):561-70. PubMed ID: 19117346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of RT-PCR monitoring on the long-term survival in acute promyelocytic leukemia.
    Hu J; Yu T; Zhao W; Gu B; Shen Z; Li X; Sun G; Chen S; Wang Z
    Chin Med J (Engl); 2000 Oct; 113(10):899-902. PubMed ID: 11775836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation between preferentially expressed antigen of melanoma and tumour necrosis factor-related apoptosis-inducing ligand gene expression in different types of leukaemia patients.
    Zhang W; Chi K; Zhang Y; Ma B; Shi J; Chen Y; Lei P; Li Y; Sun K
    Acta Haematol; 2013; 130(4):297-304. PubMed ID: 24008770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.